|
As Flu and RSV Drop, Omicron Subvariant Poses Unknown Threat
A flu and respiratory syncytial virus (RSV) season that began early and intensely already may have peaked, but other illnesses, including the XBB.1.5 omicron subvariant of the COVID-19 virus, remain threats. That makes vaccinations crucial as these illnesses converge and as children return to school post-holidays. Read more
Medicine Achieves Reduction in Medicare Physician Pay Cut Amid Push for Reform
After a concerted advocacy campaign by the Texas Medical Association and others in organized medicine, Congress lessened a Medicare physician pay cut that took effect January 1st. Despite this intervention, physicians still face declining Medicare payments in 2023 and in 2024, underscoring the need for comprehensive reform. Continue reading
Moderna Stated RSV Vaccine is Effective in Older Adults
Moderna’s vaccine against respiratory syncytial virus (RSV) was 83% effective at preventing lower respiratory tract disease in adults aged 60 and older in a large clinical trial. Based on the results, Moderna said it intends to submit the vaccine for Food and Drug Administration (FDA) approval in the first half of 2023. Read more
Call for Resolutions
Do you know an issue(s) facing medicine that should be addressed by the TMA House of Delegates? If so, the issue(s) needs to be submitted to BCMS in the form of a Resolution. As the new year begins, it is time to submit your resolution ideas and/or draft resolutions you would like the BCMS Delegation to TMA to consider. The BCMS Delegation will meet in early February to review resolutions submitted by BCMS members. Read more
|
